Package 70518-4247-0

{"route": ["ORAL"], "spl_id": "4007f7c8-71c9-60db-e063-6294a90aab3d", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["205315"], "spl_set_id": ["0c0a6774-e234-47a5-866e-462cfd99744c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 BOX (70518-4247-0)  / 1 CAPSULE, COATED PELLETS in 1 POUCH (70518-4247-1)", "package_ndc": "70518-4247-0", "marketing_start_date": "20241224"}], "brand_name": "topiramate", "product_id": "70518-4247_4007f7c8-71c9-60db-e063-6294a90aab3d", "dosage_form": "CAPSULE, COATED PELLETS", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-4247", "generic_name": "topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA078877", "marketing_category": "ANDA", "marketing_start_date": "20241224", "listing_expiration_date": "20261231"}